Cigarette smoking and gastrointestinal diseases: The causal relationship and underlying molecular mechanisms (review)

International Journal of Molecular Medicine

Volumn 34, Issue 2, 2014, Pages 372-380

  Li, Long Fei ^a   Chan, R L Y ^a   Lu, L ^a   Shen, J ^b   Zhang, L ^b   Wu, W K K ^b   Wang, L ^a   Hu, T ^a   Li, M X ^a   Cho, C H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Gastrointestinal diseases; Inflammation; Smoking

Indexed keywords

CIGARETTE SMOKE; CXCL1 CHEMOKINE; EPIDERMAL GROWTH FACTOR; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINIC RECEPTOR; POLYAMINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BILE REFLUX; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; COLORECTAL CANCER; CROHN DISEASE; DNA ADDUCT; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PANCREAS CANCER; PATHOGENESIS; PEPTIC ULCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; STOMACH ACID SECRETION; STOMACH CARCINOGENESIS; ULCERATIVE COLITIS; CARCINOGENESIS; CELL DEATH; DRUG EFFECTS; GASTROINTESTINAL DISEASES; PATHOLOGY; STOMACH MUCOSA; STOMACH NEOPLASMS;

CARCINOGENESIS; CELL DEATH; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HUMANS; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 84904247563     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1786     Document Type: Review

References (115)

1. WHO urges more countries to require large, graphic health warnings on tobacco packaging: the WHO report on the global tobacco epidemic, 2011 examines anti-tobacco mass-media campaigns. Cent Eur J Public Health 19: 133, 151, 2011.
2. Peters SA, Huxley RR and Woodward M: Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 44: 2821-2828, 2013.
3. Shin VY and Cho CH: Nicotine and gastric cancer. Alcohol 35: 259-264, 2005. (Pubitemid 41085804)
4. Chu KM, Cho CH and Shin VY: Nicotine and gastrointestinal disorders: its role in ulceration and cancer development. Curr Pharm Des 19: 5-10, 2013.
5. Peluso ME, Munnia A, Srivatanakul P, Jedpiyawongse A, Sangrajrang S, Ceppi M, Godschalk RW, van Schooten FJ and Boffetta P: DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects. Environ Mol Mutagen 54: 375-383, 2013.
6. Jain G and Jaimes EA: Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol 86: 1215-1223, 2013.
7. Li W, Zhou J, Chen L, Luo Z and Zhao Y: Lysyl oxidase, a critical intra- and extra-cellular target in the lung for cigarette smoke pathogenesis. Int J Environ Res Public Health 8: 161-184, 2011.
8. Zhang L, Ren JW, Wong CC, Wu WK, Ren SX, Shen J, Chan RL and Cho CH: Effects of cigarette smoke and its active components on ulcer formation and healing in the gastrointestinal mucosa. Curr Med Chem 19: 63-69, 2012.
9. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
10. Hecht SS: Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat Rev Cancer 3: 733-744, 2003.
11. Ootani H, Iwakiri R, Shimoda R, Nakahara S, Amemori S, Fujise T, Kikkawa A, Tsunada S, Sakata H and Fujimoto K: Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 41: 41-46, 2006.
12. Garrow D and Delegge MH: Risk factors for gastrointestinal ulcer disease in the us population. Dig Dis Sci 55: 66-72, 2010.
13. Chen MH, Wu MS, Lee WC, Wang HP and Lin JT: A multiple logistic regression analysis of risk factors in different subtypes of gastric ulcer. Hepatogastroenterology 49: 589-592, 2002.
14. Parasher G and Eastwood GL: Smoking and peptic ulcer in the Helicobacter pylori era. Eur J Gastroenterol Hepatol 12: 843-853, 2000. (Pubitemid 30663896)
15. Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M and Sorensen TI: Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology 11: 434-439, 2000. (Pubitemid 30428937)
16. Ananthakrishnan AN: Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (NY) 9: 367-374, 2013.
17. Zaharie R, Zaharie F, Mocan L, Andreica V, Tantau M, Zdrehus C, Iancu C and Tomus C: Surgical outcome of inflammatory bowel disease - experience of a tertiary center. Chirurgia (Bucur) 108: 812-815, 2013.
18. Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, et al: Crohn's disease and smoking: Is it ever too late to quit? J Crohns Colitis 7: e665-e671, 2013.
19. Lunney PC and Leong RW: Review article: Ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 36: 997-1008, 2012.
20. Somerville KW, Logan RF, Edmond M and Langman MJ: Smoking and crohn's disease. Br Med J (Clin Res Ed) 289: 954-956, 1984. (Pubitemid 14011155)
21. Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L and Cosnes J: Effects of light smoking consumption on the clinical course of Crohn's disease. Inflamm Bowel Dis 15: 734-741, 2009.
22. Harries AD, Baird A and Rhodes J: Non-smoking: A feature of ulcerative colitis. Br Med J (Clin Res Ed) 284: 706, 1982. (Pubitemid 12176825)
23. Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar C, et al: Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 19: 1010-1017, 2013.
24. Wu WK and Cho CH: The pharmacological actions of nicotine on the gastrointestinal tract. J Pharmacol Sci 94: 348-358, 2004. (Pubitemid 38590754)
25. Verschuere S, Bracke KR, Demoor T, Plantinga M, Verbrugghe P, Ferdinande L, Lambrecht BN, Brusselle GG and Cuvelier CA: Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab Invest 91: 1056-1067, 2011.
26. Wang H, Ma L, Li Y and Cho CH: Exposure to cigarette smoke increases apoptosis in the rat gastric mucosa through a reactive oxygen species-mediated and p53-independent pathway. Free Radic Biol Med 28: 1125-1131, 2000. (Pubitemid 30314711)
27. Sharma A, Neekhra A, Gramajo AL, Patil J, Chwa M, Kuppermann BD and Kenney MC: Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci 49: 5111-5117, 2008.
28. FitzGerald AJ, Mandir N and Goodlad RA: Leptin, cell proliferation and crypt fission in the gastrointestinal tract of intravenously fed rats. Cell Prolif 38: 25-33, 2005. (Pubitemid 40229265)
29. Ma L, Wang WP, Chow JY, Yuen ST and Cho CH: Reduction of EGF is associated with the delay of ulcer healing by cigarette smoking. Am J Physiol Gastrointest Liver Physiol 278: G10-G17, 2000. (Pubitemid 30108062)
30. Shin VY, Liu ES, Koo MW, Wang JY, Matsui H and Cho CH: Cigarette smoke extracts delay wound healing in the stomach: Involvement of polyamine synthesis. Exp Biol Med (Maywood) 227: 114-124, 2002.
31. Konturek JW, Bielanski W, Konturek SJ, Bogdal J and Oleksy J: Distribution and release of epidermal growth factor in man. Gut 30: 1194-1200, 1989. (Pubitemid 19255426)
32. Ma L, Wang WP, Chow JY, Lam SK and Cho CH: The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract. Gut 47: 170-177, 2000. (Pubitemid 30489758)
33. Brzozowski T, Konturek SJ, Majka J, Dembinski A and Drozdowicz D: Epidermal growth factor, polyamines, and prostaglandins in healing of stress-induced gastric lesions in rats. Dig Dis Sci 38: 276-283, 1993. (Pubitemid 23054360)
34. Konturek JW, Brzozowski T and Konturek SJ: Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroenterol 13 (Suppl 1): S88-S97, 1991.
35. Maity P, Biswas K, Roy S, Banerjee RK and Bandyopadhyay U: Smoking and the pathogenesis of gastroduodenal ulcer - recent mechanistic update. Mol Cell Biochem 253: 329-338, 2003. (Pubitemid 37321740)
36. Mertz DP and Thongbhoubesra T: Effect of nicotine on the production of gastric acid (author's transl). Med Klin 71: 147-155, 1976 (In German).
37. Ligny G, Van Ccauter J and Henry JP: The effect of cigarette smoking on the cicatrization of duodenal ulcers in patients treated with cimetidine. The role of acid hypersecretion. Rev Med Brux 10: 233-238, 1989 (In French). (Pubitemid 19159882)
38. Fiddian-Green R, Russell RC and Hobsley M: Pyloric reflux in duodenal ulceration and its relationship to smoking. Br J Surg 60: 321, 1973.
39. Read NW and Grech P: Effect of cigarette smoking on competence of the pylorus: preliminary study. Br Med J 3: 313-316, 1973.
40. Valenzuela JE, Defilippi C and Csendes A: Manometric studies on the human pyloric sphincter. Effect of cigarette smoking, metoclopramide, and atropine. Gastroenterology 70: 481-483, 1976.
41. Bynum TE, Solomon TE, Johnson LR and Jacobson ED: Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13: 361-365, 1972.
42. Bochenek WJ and Koronczewski R: Effects of cigarette smoking on bicarbonate and volume of duodenal contents. Am J Dig Dis 18: 729-733, 1973.
43. Murthy SN, Dinoso VP Jr, Clearfield HR and Chey WY: Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73: 758-761, 1977. (Pubitemid 8210072)
44. Deng B, Li Y, Zhang Y, Bai L and Yang P: Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis. Carcinogenesis 34: 1189-1195, 2013.
45. Bures J, Kopacova M, Skodova Fendrichova M and Rejchrt S: Epidemiology of Helicobacter pylori infection. Vnitr Lek 57: 993-999, 2011 (In Czech).
46. Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, Miki K, Kaneko E and Mizukoshi H: Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol 15: 271-276, 2000. (Pubitemid 30190740)
47. Arkkila PE, Kokkola A, Seppälä K and Sipponen P: Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol 42: 695-701, 2007. (Pubitemid 46763586)
48. Endoh K and Leung FW: Effects of smoking and nicotine on the gastric mucosa: a review of clinical and experimental evidence. Gastroenterology 107: 864-878, 1994. (Pubitemid 24265537)
49. Smith SM and Kvietys PR: Gastric ulcers: Role of oxygen radicals. Crit Care Med 16: 892-898, 1988.
50. Hirota M, Inoue M, Ando Y and Morino Y: Inhibition of stress-induced gastric mucosal injury by a long acting superoxide dismutase that circulates bound to albumin. Arch Biochem Biophys 280: 269-273, 1990. (Pubitemid 20221963)
51. Calvino Fernández M and Parra Cid T: H. pylori and mitochondrial changes in epithelial cells. The role of oxidative stress. Rev Esp Enferm Dig 102: 41-50, 2010.
52. Church DF and Pryor WA: Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985. (Pubitemid 16135783)
53. Kalra J, Chaudhary AK and Prasad K: Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 72: 1-7, 1991.
54. Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377, 2002.
55. Chow JY, Ma L and Cho CH: Involvement of free radicals and histamine in the potentiating action of cigarette smoke exposure on ethanol-induced gastric mucosal damage in rats. Free Radic Biol Med 24: 1285-1293, 1998. (Pubitemid 28246744)
56. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
57. Tang Y, Kassie F, Qian X, Ansha B and Turesky RJ: DNA adduct formation of 2-amino-9H-pyrido[2,3-b)indole and 2-amino-3,4-dimethylimidazo[4,5-f)quinoline in mouse liver and extrahepatic tissues during a subchronic feeding study. Toxicol Sci 133: 248-258, 2013.
58. Martin JW, Mousa SS, Shaker O and Mousa SA: The multiple faces of nicotine and its implications in tissue and wound repair. Exp Dermatol 18: 497-505, 2009.
59. Zong Y, Zhang ST and Zhu ST: Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide. World J Gastroenterol 15: 2500-2505, 2009.
60. Cucina A, Dinicola S, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A and Bizzarri M: Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways. J Surg Res 178: 233-241, 2012.
61. Seitz HK and Cho CH: Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 472: 217-241, 2009.
62. Castellsagué X, Muñoz N, De Stefani E, Victora CG, Castelletto R, Rolón PA and Quintana MJ: Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 82: 657-664, 1999. (Pubitemid 29356963)
63. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR and Schatzkin A: A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165: 1424-1433, 2007. (Pubitemid 47234314)
64. Yaegashi Y, Onoda T, Morioka S, Hashimoto T, Takeshita T, Sakata K and Tamakoshi A: Joint effects of smoking and alcohol drinking on esophageal cancer mortality in Japanese men: Findings from the Japan collaborative cohort study. Asian Pac J Cancer Prev 15: 1023-1029, 2014.
65. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A, Dosemeci M, et al: Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 153: 114-122, 2001. (Pubitemid 32063186)
66. Radoï L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Schmaus A, Cénée S, Menvielle G, Carton M, Lapôtre-Ledoux B, Delafosse P, et al: Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite: results of a French populationbased case-control study, the ICARE study. Eur J Cancer Prev 22: 268-276, 2013.
67. Pentenero M, Giaretti W, Navone R, Rostan I, Gassino L, Broccoletti R, Arduino PG, Malacarne D and Gandolfo S: Evidence for a possible anatomical subsite-mediated effect of tobacco in oral potentially malignant disorders and carcinoma. J Oral Pathol Med 40: 214-217, 2011.
68. Muwonge R, Ramadas K, Sankila R, Thara S, Thomas G, Vinoda J and Sankaranarayanan R: Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol 44: 446-454, 2008. (Pubitemid 351608615)
69. Sasazuki S, Sasaki S and Tsugane S: Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 101: 560-566, 2002.
70. Moy KA, Fan Y, Wang R, Gao YT, Yu MC and Yuan JM: Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 19: 2287-2297, 2010.
71. Eguchi H and Nakachi K: Smoking as a risk factor for pancreatic cancer. Nihon Rinsho 64 (Suppl 1): S10-S13, 2006 (In Japanese).
72. Yun JE, Jo I, Park J, Kim MT, Ryu HG, Odongua N, Kim E and Jee SH: Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in korean men. Int J Cancer 119: 208-212, 2006.
73. Farris SM, Pettrey C and Daly KC: A subpopulation of mushroom body intrinsic neurons is generated by protocerebral neuroblasts in the tobacco hornworm moth, Manduca sexta (Sphingidae, Lepidoptera). Arthropod Struct Dev 40: 395-408, 2011.
74. Phipps AI, Shi Q, Newcomb PA, Nelson GD, Sargent DJ, Alberts SR and Limburg PJ: Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol 31: 2016-2023, 2013.
75. Schuller HM: Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9: 195-205, 2009.
76. Zhao Y, Zhou W, Xue L, Zhang W and Zhan Q: Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC). PLoS One 9: e90836, 2014.
77. Chernyavsky AI, Arredondo J, Vetter DE and Grando SA: Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. Exp Cell Res 313: 3542-3555, 2007. (Pubitemid 47404552)
78. Wong HP, Yu L, Lam EK, Tai EK, Wu WK and Cho CH: Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma ht-29 cells. Toxicol Appl Pharmacol 221: 261-267, 2007. (Pubitemid 46855813)
79. Wong HP, Yu L, Lam EK, Tai EK, Wu WK and Cho CH: Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 97: 279-287, 2007. (Pubitemid 47073845)
80. Jarabek AM, Pottenger LH, Andrews LS, Casciano D, Embry MR, Kim JH, Preston RJ, Reddy MV, Schoeny R, Shuker D, Skare J, et al: Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Crit Rev Toxicol 39: 659-678, 2009.
81. Dyke GW, Craven JL, Hall R and Garner RC: Smoking-related DNA adducts in human gastric cancers. Int J Cancer 52: 847-850, 1992. (Pubitemid 23009496)
82. Bartsch H, Ohshima H, Pignatelli B and Calmels S: Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv 8: 335-362, 1989. (Pubitemid 20035379)
83. Pabiszczak M, Szmeja Z, Szyfter K and Szyfter W: Analysis of aromatic DNA adducts in oral cavity and pharyngeal cancer. Otolaryngol Pol 54: 151-156, 2000 (In Polish).
84. Lee JM, Liu TY, Wu DC, Tang HC, Leh J, Wu MT, Hsu HH, Huang PM, Chen JS, Lee CJ and Lee YC: Safrole-DNA adducts in tissues from esophageal cancer patients: Clues to areca-related esophageal carcinogenesis. Mutat Res 565: 121-128, 2005. (Pubitemid 40127574)
85. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P and Li D: DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 58: 38-41, 1998. (Pubitemid 28027713)
86. Al-Saleh I, Arif J, El-Doush I, Al-Sanea N, Jabbar AA, Billedo G, Shinwari N, Mashhour A and Mohamed G: Carcinogen DNA adducts and the risk of colon cancer: case-control study. Biomarkers 13: 201-216, 2008. (Pubitemid 351250366)
87. Hecht SS: Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 26: 163-181, 1996.
88. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD and Anderson MW: Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res 49: 5305-5311, 1989. (Pubitemid 19240465)
89. Askari MD, Tsao MS and Schuller HM: The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131: 639-648, 2005. (Pubitemid 41502206)
90. Colotta F, Allavena P, Sica A, Garlanda C and Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081, 2009.
91. Liu ES, Ye YN, Shin VY, Yuen ST, Leung SY, Wong BC and Cho CH: Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 24: 1407-1413, 2003. (Pubitemid 37038830)
92. van Horssen R, Ten Hagen TL and Eggermont AM: TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11: 397-408, 2006.
93. Wheelhouse NM, Chan YS, Gillies SE, Caldwell H, Ross JA, Harrison DJ and Prost S: TNF-α induced DNA damage in primary murine hepatocytes. Int J Mol Med 12: 889-894, 2003.
94. Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P, Thompson RG, Kollias G, Smyth JF, Balkwill FR and Hagemann T: The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119: 3011-3023, 2009.
95. Idriss HT and Naismith JH: TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50: 184-195, 2000. (Pubitemid 30610095)
96. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM and Oshima M: Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 27: 1671-1681, 2008.
97. Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC and Hsieh SL: Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 111: 5054-5063, 2008.
98. Chung YC and Chang YF: Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83: 222-226, 2003.
99. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, Heath JK and Ernst M: Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8: 1089-1097, 2002. (Pubitemid 35175963)
100. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B and Lahm H: Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 151: 31-38, 2000. (Pubitemid 30155582)
101. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, et al: TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501, 2004. (Pubitemid 39370505)
102. Candido J and Hagemann T: Cancer-related inflammation. J Clin Immunol 33 (Suppl 1): S79-S84, 2013.
103. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA and Karin M: Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694, 2007. (Pubitemid 46606879)
104. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA and Apte RN: Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 67: 1062-1071, 2007.
105. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645-2650, 2003. (Pubitemid 36297552)
106. Carmi Y, Dotan S, Rider P, Kaplanov I, White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN and Voronov E: The role of IL-1β in the early tumor cell-induced angiogenic response. J Immunol 190: 3500-3509, 2013.
107. Dimberg A: Chemokines in angiogenesis. Curr Top Microbiol Immunol 341: 59-80, 2010.
108. Wilson J and Balkwill F: The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12: 113-120, 2002. (Pubitemid 34680740)
109. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK and DuBois RN: CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203: 941-951, 2006.
110. Erreni M, Bianchi P, Laghi L, Mirolo M, Fabbri M, Locati M, Mantovani A and Allavena P: Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol 460: 105-121, 2009.
111. Gales D, Clark C, Manne U and Samuel T: The chemokine CXCL8 in carcinogenesis and drug response. ISRN Oncol 2013: 859154, 2013.
112. Vandercappellen J, Van Damme J and Struyf S: The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244, 2008.
113. Luppi F, Longo AM, de Boer WI, Rabe KF and Hiemstra PS: Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56: 25-33, 2007. (Pubitemid 46356635)
114. Richardson RM, Ali H, Pridgen BC, Haribabu B and Snyderman R: Multiple signaling pathways of human interleukin-8 receptor A. Independent regulation by phosphorylation. J Biol Chem 273: 10690-10695, 1998. (Pubitemid 28227683)
115. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA and Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6: 2104-2119, 2000. (Pubitemid 30305111)